RBD7007 has demonstrated robust, long-lasting inhibition of complement pathway activation in preclinical studies, along with an excellent safety profile. The Swedish Medicinal Product Agency has ...

Patients with a serum IgG4 decrease greater than 0.65 had significantly lower relapse rates compared with those with a slower rate of decrease. Researchers in Japan have identified key factors that ...

The researchers found that HPA-15b was more common than HPA-15a, which contradicts common nomenclature conventions. A team from the University General Hospital of Thessaloniki has created the first ...

Elevated serum IgG4 is a hallmark of IgG4-RD but not primary Sjögren syndrome, where IgG4 levels may be decreased. Elevated serum immunoglobulin G4 (IgG4) levels are typically associated with ...

Radiation therapy, but not surgery, is the only protective factor against poor functional outcomes. Patients with primary central nervous system lymphoma (PCNSL) who received gross total resection ...

There is an urgent need to increase awareness of the symptoms and treatment options for ATTR-PN among patients and physicians, the authors concluded. The perspectives of a physician and a patient with ...

The new study will measure outcomes including platelet levels at birth and fetal and neonatal deaths. A new phase 3 study is set to launch in 2025 to assess the safety and efficacy of nipocalimab in ...

Over 90% of the bone marrow and all of the cerebrospinal fluid lymphoblasts expressed CD49f at the time of ALL diagnosis. Integrin α6, also known as CD49f can be used as a marker of measurable ...

The number of needle redirections was significantly lower in patients treated with ultrasound assistance compared to those treated without. Ultrasound assistance reduces the number of needle ...

RLYB212 holds promise as a prophylactic option for preventing FNAIT by accelerating the elimination of HPA-1a-positive platelets and potentially preventing maternal alloimmunization. Results from a ...

The most commonly used imaging modality is computed tomography angiography, representing 49.1% of the imaging modalities used, followed by PET/CT, which accounts for 33.8%. Among patients with ...

The study will record the incidence, type, and course of infections, hemolysis rates after treatment discontinuation, and adverse events. A new study will observe outcomes from the use of iptacopan ...